Holubkov Richard, Laskey Warren K, Haviland Amelia, Slater James C, Bourassa Martial G, Vlachos Helen Aslanidou, Cohen Howard A, Williams David O, Kelsey Sheryl F, Detre Katherine M
Department of Epidemiology, Cardiovascular Institute, University of Pittsburgh, Pittsburgh, Pa 15261, USA.
Am Heart J. 2002 Nov;144(5):826-33. doi: 10.1067/mhj.2002.125505.
As percutaneous coronary intervention (PCI) is most commonly performed for relief of angina, it is important to identify factors associated with recurrence of anginal symptoms.
We examined symptoms at 1-year follow-up in 1755 consecutive NHLBI Dynamic Registry patients who underwent PCI in the setting of symptoms or acute infarction.
At 1-year follow-up, 26% of patients reported angina in the previous 6 weeks. Younger patients and females reported more symptoms. History of coronary artery bypass graft (CABG) or PCI, prior myocardial infarction (MI), diabetes, graft disease, and extensive coronary artery disease (CAD) (>4 significant lesions) were also associated with follow-up angina. Patients receiving stents reported less angina (24% vs 29%, P <.05). Completely revascularized patients and those with residual single-vessel disease had comparable 1-year angina rates (23% both subgroups), while 32% of patients with residual multivessel CAD reported symptoms. Patients undergoing repeat PCI during follow-up reported more 1-year angina than others (34% vs 24%, P <.001), whereas those undergoing CABG after post-PCI hospitalization had less symptoms (15% vs 26%, P <.05). After adjustment for baseline symptom status and outcome of index PCI, residual CAD, and reintervention during follow-up, patient characteristics significantly predictive of angina included female sex, age <62 years, and prior MI.
While approximately three quarters of patients receiving PCI are angina-free at 1 year, females continue to have more symptoms, as do other subgroups including patients with history of MI or previous intervention. As these symptoms are associated with self-reported activity and quality of life limitation, evaluations of PCI should include angina as a key follow-up outcome.
由于经皮冠状动脉介入治疗(PCI)最常用于缓解心绞痛,因此识别与心绞痛症状复发相关的因素很重要。
我们对1755例连续的美国国立心肺血液研究所(NHLBI)动态注册研究患者进行了1年随访,这些患者在出现症状或急性心肌梗死时接受了PCI治疗。
在1年随访时,26%的患者报告在过去6周内有心绞痛。年轻患者和女性报告的症状更多。冠状动脉旁路移植术(CABG)或PCI病史、既往心肌梗死(MI)、糖尿病、移植血管病变和广泛冠状动脉疾病(CAD)(>4处严重病变)也与随访时的心绞痛有关。接受支架置入的患者心绞痛发生率较低(24%对29%,P<.05)。完全血运重建的患者和残留单支血管病变的患者1年心绞痛发生率相当(两个亚组均为23%),而残留多支血管CAD的患者中有32%报告有症状。随访期间接受重复PCI的患者1年心绞痛发生率高于其他患者(34%对24%,P<.001),而PCI术后住院期间接受CABG的患者症状较少(15%对26%,P<.05)。在对基线症状状态、首次PCI结果、残留CAD以及随访期间的再次干预进行调整后,显著预测心绞痛的患者特征包括女性、年龄<62岁和既往MI。
虽然约四分之三接受PCI的患者在1年时无心绞痛,但女性以及包括有MI病史或既往干预史的其他亚组患者症状仍然更多。由于这些症状与自我报告的活动和生活质量受限有关,PCI评估应将心绞痛作为关键的随访结果。